Shanghai - Delayed Quote CNY
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
67.20
-1.33
(-1.94%)
At close: May 13 at 3:00:02 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,893,515.76
2,245,403.25
5,510,782.51
11,185,188.72
5,750,329.07
Cost of Revenue
666,982.95
759,044.72
873,242.27
1,170,412.04
817,710.61
Gross Profit
1,226,532.81
1,486,358.52
4,637,540.25
10,014,776.68
4,932,618.46
Operating Expense
1,373,572.26
1,484,058.05
3,015,657.94
4,415,195.11
2,496,240.01
Operating Income
-147,039.45
2,300.48
1,621,882.31
5,599,581.57
2,436,378.46
Net Non Operating Interest Income Expense
38,112.32
50,644.60
79,963.28
33,725.17
3,550.50
Pretax Income
-116,059.13
67,480.83
1,393,391.83
5,582,691.09
2,324,145.35
Tax Provision
-41,228.01
-41,613.69
146,887.44
719,389.94
244,931.14
Net Income Common Stockholders
-72,249.67
106,235.43
1,247,679.72
4,735,795.24
2,021,467.67
Basic EPS
-0.06
0.08
0.99
3.79
1.64
Diluted EPS
-0.06
0.08
0.99
3.79
1.64
Basic Average Shares
1,343,528.36
1,327,942.82
1,260,282.55
1,249,550.20
1,230,458.58
Diluted Average Shares
1,343,528.36
1,327,942.82
1,260,282.55
1,249,550.20
1,230,458.58
Total Operating Income as Reported
-89,879.68
93,837.66
1,401,450.91
5,596,038.04
2,328,455.80
Total Expenses
2,040,555.20
2,243,102.77
3,888,900.21
5,585,607.15
3,313,950.62
Net Income from Continuing & Discontinued Operation
-72,249.67
106,235.43
1,247,679.72
4,735,795.24
2,021,467.67
Normalized Income
-21,638.47
163,360.53
1,615,195.65
4,820,633.12
2,122,198.67
Interest Income
45,466.62
59,455.69
87,977.40
42,151.10
9,771.60
Interest Expense
8,623.98
8,324.93
6,860.37
7,669.72
5,691.15
Net Interest Income
38,112.32
50,644.60
79,963.28
33,725.17
3,550.50
EBIT
-107,435.15
75,805.76
1,400,252.20
5,590,360.82
2,329,836.50
EBITDA
-107,435.15
376,456.59
1,631,766.80
5,742,261.09
2,435,112.29
Reconciled Cost of Revenue
666,982.95
759,044.72
873,242.27
1,170,412.04
817,710.61
Reconciled Depreciation
--
300,650.83
231,514.60
151,900.27
105,275.80
Net Income from Continuing Operation Net Minority Interest
-72,249.67
106,235.43
1,247,679.72
4,735,795.24
2,021,467.67
Total Unusual Items Excluding Goodwill
-78,495.31
-76,166.81
-410,823.82
-97,387.28
-112,597.10
Total Unusual Items
-78,495.31
-76,166.81
-410,823.82
-97,387.28
-112,597.10
Normalized EBITDA
-28,939.85
452,623.40
2,042,590.62
5,839,648.37
2,547,709.40
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-27,884.11
-19,041.70
-43,307.89
-12,549.40
-11,866.10
12/31/2021 - 4/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade